Ace inhibitors : medical uses, mechanisms of action, potential adverse effects and related topics
| Main Author: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
New York :
Nova Biomedical ,
c2015
|
| Subjects: |
Table of Contents:
- 1. The introduction of angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) into clinical medicine and the mechanisms of actions of ACEIs and ARBs
- 2. RCTs revisited: a nephrologist's critique of randomized controlled trials in the nephrology literature
- 3. The abuse of renal surrogates and combination renal endpoints in nephrology RCTs
- 4. The CKD enigma, reengineering CKD care, narrowing asymmetric information and confronting ethicomedicinomics in CKD care: the introduction of the new 'CKD express 'IT sofeware program
- 5. The "triple whammy" challenge revisited - ACEIs, diuretics and NSAIDs: a European 21st century perspective
- 6. "Quadruple whammy": a newly described preventable syndrome of peri-operative AKI on CKD in patients on concurrent "triple whammy" medications
- 7. Late onset renal failure from angiotensin blockade (LORFFAB) - the results of a mayo clinic health system angiotensin inhibition withdrawal study: a clarion call for more preventative nephrology, also called renoprevention
- 8. Acute kidney injury on chronic kidney disease - the rainbow syndrome of too many colors: a mayo clinic health system case series report
- 9. The syndrome of rapid onset ESRD in the ast 100 consecutive incident northewstern wisconsin mayo clinic chronic hemodialysis patients, 2010-2011: results of the analysis of individual patient-level serum creatinine trajectories to ESRD - can there be a link with angiotensin inhibition and renal senescence in older CKD patients?
- 10. Geriatric nephrology debate: angiotensin inhibition should be withdrawn in older adults with later stage CKD: a 2013 mayo clinic health system nephrologist's and the unmet need for newer kidney-friendly renoprotective agents for the 21st century
- 11. Zefenopril: a sulphydryl ACE inhibitor endowed with antioxidant and cardioprotective endowed with antioxidant and cardioprotective activity
- 12. Molecular mechanisms and pharmacological implications of MMP-9 inhibition by ACE inhibition
- 13. Hypertension and angiotensin-converting enzyme inhibitors in rat cardiac microvessels - a mini review of histochemical microvascular studies
- 14. Action mechanism of angiotensin i-converting enzyme inhibitory peptides derived from cowpea (vigna unguiculata)
- 15. Effect of angiotensin-converting enzyme inhibitors on arterial stiffness and endothelial dysfunction: a comprehensive review